Search
for
Sort by
Research 181–210 of 1000+
- 6 Current concepts of polycystic ovary syndrome
- High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Suppression of uterine and placental ferroptosis by N-acetylcysteine in a rat model of polycystic ovary syndrome
- Endocrine and metabolic characteristics in polycystic ovary syndrome.
- Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- EFFECTS OF A LOW‐DOSE DESOGESTREL‐ETHINYLESTRADIOL COMBINATION ON HIRSUTISM, ANDROGENS AND SEX HORMONE BINDING GLOBULIN IN WOMEN WITH A POLYCYSTIC OVARY SYNDROME
- Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- ANTIANDROGEN TREATMENT OF POLYCYSTIC OVARY SYNDROME
- The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study
- Elevated Ghrelin Plasma Levels in Patients with Polycystic Ovary Syndrome
- Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
- MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Health-related quality of life and psychological distress in polycystic ovary syndrome: a hidden facet in South Asian women
- Polycystic Ovary Syndrome: Early Detection in the Adolescent
- Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Polycystic Ovary Syndrome: A Common But Often Unrecognized Condition
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome
- Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management